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Abstract The prevalence of nephrocalcinosis (NC) in
preterm neonates in recent reports is 7–41%. The wide
range in prevalence is a consequence of different study
populations and ultrasound equipment and criteria, in
addition to a moderate interobserver variation. NC in
preterm neonates has a multifactorial aetiology, consisting
of low gestational age and birth weight, often in combina-
tion with severe respiratory disease, and occurs as a result
of an imbalance between stone-promoting and stone-
inhibiting factors. A limited number of histological studies
suggest that calcium oxalate crystals play an important role
in NC in premature neonates. In 85% of children resolution
of NC occurs in the first years of life. Prematurity, per se, is
associated with high blood pressure, relatively small
kidneys, and (distal) tubular dysfunction. In addition, NC
in preterm neonates can have long-term sequelae for
glomerular and tubular function. Long-term follow-up of
blood pressure and renal function of prematurely born
children, especially with neonatal NC, is recommended.
Prevention of NC with (low) oral doses of citrate has not
resulted in a significant decrease in the prevalence of NC; a
higher citrate dosage deserves further study. Future research
pertaining to prevention of NC in preterm neonates is crucial.
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Introduction
Nephrocalcinosis (NC), defined as renal calcification, was
first described by Hufnagle et al. in 1982 in premature
neonates who received long-term furosemide therapy [1].
NC in preterm neonates occurs as a result of imbalance
between stone-promoting and stone-inhibiting factors. The
aetiology of NC is multifactorial and comprehensive and
will be discussed in detail.
As nephrogenesis is not completed until 34–36 weeks of
gestation, the development of the kidneys, both anatomical
and functional, is not completed at birth [2]. After birth,
rapid changes in functional development occur. Injury to
the kidneys in this period can affect renal function later in
life [3]. There is growing evidence of an association of low
birth weight with low nephron numbers and subsequent risk
for adult cardiovascular disease and renal insufficiency [4].
However, full consensus has not been established, as recent
studies do not fully support the hypothesis that low birth
weight contributes to impaired kidney function, at least not
until the age of 20–26 years [5, 6]. Nevertheless,
development of NC in prematurely born children may
carry an additional risk of compromising renal function
later in life.
We will discuss prevalence, radiological and histological
diagnosis, aetiology, natural course and long-term effects,
in addition to prevention and treatment of NC in preterm
neonates.
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Prevalence of nephrocalcinosis
NC is diagnosed in 7–64% of preterm neonates with
gestational age <32 weeks or birth weight <1,500 g [7–
16]. The wide range in prevalence of NC is a consequence
of different study populations and ultrasound equipment and
criteria, in addition to a moderate interobserver variation
[12]. Recent studies have noted a slightly lower prevalence
of 7–41% than in the original reports [12–16].
Diagnosis of nephrocalcinosis
Radiological evaluation
NC can be detected by conventional radiography, ultraso-
nography (Fig. 1) or computer tomography (CT). Ultraso-
nography is more sensitive than conventional radiography
[17]. In rabbits with NC, ultrasound was more sensitive than
CT (96% vs 64%), but CTwas more specific than ultrasound
(96% vs 85%) [18]. As CT involves a high radiation dose, it
is unsuitable to detect NC in preterm neonates. Ultrasonog-
raphy is a reliable method for screening and grading of
young children with risk of NC, with good intra- and
interobserver agreement (kappa coefficient, respectively,
0.80 and 0.76) [19]. Reproducibility of ultrasound in
detecting NC in preterm neonates has a very good intra-
observer agreement (kappa 0.84), but a moderate interob-
server agreement (kappa 0.46) [12]. NC was located
exclusively in the medulla in more than 95% of kidneys [12].
However, increased medullary echogenicity in the
preterm neonate is not exclusively found in NC, but also
in other conditions, such as renal candidiasis, cytomegalo-
virus infection, acute renal failure, polycystic kidney
disease, renal vein thrombosis, or as a transient spontane-
ously resolving phenomenon of unclear aetiology in the
first postnatal week [20–26].
Histological evaluation
NC is defined as mineral precipitates located in the renal
parenchyma. Knowledge of the pathological aspects of the
ultrasound findings in preterm neonates is scarce. Histo-
logical examination of a few kidneys of preterm neonates
with medullary echogenicity showed calcifications, located
either within the tubules or in the interstitium, consisting of
calcium oxalate or calcium phosphate crystals [1, 10, 27–
29]. Renal histology of 44 infants and neonates who had
died after intensive care treatment between 1972 and 1992
was compared with that of 64 infants and neonates who had
died without intensive care treatment [29]. Intratubular
calcium oxalate deposits were found in eight of the
intensive care-treated patients, whereas two of these cases
in addition showed intratubular calcium phosphate deposits,
which, in one patient, extended into the interstitium. The
patients without intensive care treatment, on the other hand,
demonstrated minimal calcium phosphate microliths in two
cases, but no oxalate crystals. This suggests that calcium
oxalate crystals play an important role in NC in intensive
care-treated patients.
Aetiology of nephrocalcinosis in preterm neonates
NC in preterm neonates has a multifactorial aetiology,
consisting of low gestational age and birth weight [1, 7–9,
13, 14, 30], often in combination with severe respiratory
disease [8, 13, 14, 30, 31], and it occurs as a result of an
imbalance between stone-promoting and stone-inhibiting
factors (Table 1). There is a clear correlation between
prevalence of NC and low gestational age [7–9, 13, 14, 30].
Premature kidneys have relatively well-developed deep
nephrons, with a long loop of Henle and probably low urine
velocity. As a result, conditions are favourable for the
formation of crystals, which can stick to the surface and
Fig. 1 a Renal ultrasound of a preterm neonate with moderate
nephrocalcinosis, with small white flecks in the tip of the pyramids. b
Ultrasound of kidney of a preterm neonate with severe nephrocalci-
nosis. White dots almost entirely fill the pyramids
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grow and aggregate in the tubules. Under these circum-
stances stone-promoting factors such as hypercalciuria and
hyperoxaluria, as described below, in combination with
reduced stone-inhibiting factors like low urinary citrate
excretion, can lead to NC.
Of course, other well-known causes of NC, such as
primary hyperoxaluria, distal tubular acidosis, glucose–
galactose malabsorption, Bartter’s syndrome, Williams’
syndrome, and hypophosphatasia, can also occur in preterm
neonates [32–35]. Here, we will focus on NC of prematurity.
Factors promoting nephrocalcinosis
Factors promoting nephrocalcinosis are shown in Table 1.
Hypercalciuria
Mean urinary calcium/creatinine ratio in preterm neonates
varies from 2.3–2.7 mmol/mmol, which is much higher
than reference values for term neonates and older children
(<0.6–0.9 mmol/mmol) [30, 36]. On the other hand,
considerable variation is reported, with much lower
(median 0.31 mmol/mmol) as well as much higher (mean
4 mg/mg=11.4 mmol/mmol) values [37, 38].
Furosemide Several (early) studies indicated furosemide for
chronic lung disease to be the most important aetiological
factor in the development of NC in preterm neonates [1, 7,
39]. Reabsorption of calcium in the loop of Henle is
primarily passive, driven by the gradient created by sodium
chloride (NaCl) transport. Inhibition by furosemide of the
Na+ K+-2Cl− carrier in the apical membrane leads to a
parallel reduction in the reabsorption of calcium and, hence,
to hypercalciuria [40]. In preterm neonates calciuresis may
be prolonged due to slower plasma clearance [41, 42].
However, development of NC has also been described in
preterm neonates without furosemide therapy [8, 43].
Glucocorticoids Many preterm neonates receive glucocor-
ticoids for treatment or prevention of chronic lung disease
[44–46]. High doses of glucocorticoids can lead to
osteopenia, hypercalciuria and nephrolithiasis. The patho-
genesis relates to an imbalance between resorption and
formation of bone. An association between dexamethasone
treatment, high calcium excretion and NC is, indeed, found
in preterm neonates [13, 30, 47, 48].
Methylxanthines Caffeine and theophylline, both methyl-
xanthines, are frequently prescribed to prevent apnoea in
preterm neonates and are also known for their hyper-
calciuric effect. Urinary calcium excretion rose two- to ten-
fold in preterm neonates treated with methylxanthines in
comparison with a control group [49, 50]. In keeping with
this concept, a significant correlation was noted between
theophylline prescription and NC in preterm neonates [30].
Suggested mechanisms to explain the hypercalciuria are
increased diuresis and natriuresis, increased prostaglandin
synthesis, and antagonism of adenosine-mediated effects
with a change in renal blood flow and glomerular filtration
rate [49, 51].
Acidosis Preterm neonates may experience periods of
respiratory and/or metabolic acidosis. Acidosis results in a
number of changes in adults that increase the risk of stone
formation: increased urinary calcium as a result of bone
buffering, decreased urinary citrate by increased reabsorp-
tion in the proximal tubule and decreased urinary pH [52].
Significantly more preterm neonates with NC show a
tendency toward metabolic acidosis than those without
NC [15].
Calcium intake As 80% of calcium and phosphorus
accumulate in the fetus between the 25th post-conceptional
week and full term, the majority of bone accumulation in
preterm neonates takes place after birth [53]. Consequently,
to prevent rickets of prematurity, the recommended intake
of calcium (100–160 mg/kg per day) is high in comparison
with that for full-term neonates [54]. High calcium intake
is confirmed as a risk factor for NC in preterm neonates
[30].
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Vitamin D intake Vitamin D excess can result in hyper-
calcaemia and hypercalciuria. In order to prevent rickets,
the intake of vitamin D in preterm neonates is relatively
high. Recent guidelines advise an intake of 800–1,000 IU
[54]. In spite of this, vitamin D has not been found to be a
risk factor for NC. Vitamin D intake and vitamin 1,25
(OH)2-vitamin D3 plasma levels were equal in preterm
neonates compared with those without NC [30].
Phosphorus intake Recommended phosphorus intake for
preterm neonates is 60–90 mg/kg per day and is like
calcium intake, high in comparison with that for term
neonates [54]. Phosphorus intake can influence the risk of
developing NC in two ways.
Low intake of phosphorus can result in hypophosphataemia.
Hypophosphataemia leads to a rise in phosphorus reab-
sorption in the proximal tubules, an increase in calcium and
phosphorus absorption from the bone, and an increase in
renal production of 1,25(OH)2-vitamin D3. Vitamin D
stimulates the intestinal absorption and resorption of
calcium and phosphorus from the bone. The consequent
increase in serum calcium induces suppression of parathor-
mone release, which results in a further decrease in urine
phosphate and an increase in calcium excretion in adults
[55]. In line with this hypothesis, Hein et al. confirmed that
significantly more preterm neonates with NC had transient
hypophosphataemia and hypercalciuria than did preterm
neonates without NC [15]. In contrast Schell-Feith et al. did
not find a difference in serum phosphate between preterm
neonates with and without NC [30].
In contrast, a high intake of phosphorus is also
associated with NC in preterm neonates [11, 30]. In
addition, a high intake of phosphorus can lead to secondary
hyperoxaluria, as will be explained later.
Sodium intake In children and adults sodium intake and
excretion are linked to urinary calcium excretion and can
result in hypercalciuria. Similarly, sodium excretion in
preterm neonates is positively correlated with urinary
calcium excretion [56]. Nonetheless, the correlation be-
tween sodium excretion and occurrence of NC in preterm
neonates has not yet been studied.
Parenteral nutrition In preterm neonates on parenteral
nutrition urinary calcium/citrate ratio increased in the first
10 days of life, while in human-milk-fed infants this ratio
decreased, which indicates a higher risk of renal calcifica-
tions in preterm neonates fed parenterally [57]. Narendra et
al. confirmed that NC occurs more frequently in preterm
neonates with longer duration of parenteral nutrition [13],
while Schell-Feith et al. could not find such a correlation
[30].
Hyperoxaluria
As NC in preterm neonates can consist of calcium oxalate
precipitates, high urinary excretion of oxalate might be an
important factor in the development of NC [1, 29]. Hoppe
et al. demonstrated that preterm neonates excrete more
oxalate in the first months of life than do full-term
neonates [58]. An association with higher urine oxalate/
creatinine ratio was found in preterm neonates with NC as
opposed to those without NC by some [13, 59], but not by
others [30].
Precursors of oxalate Ascorbic acid and glycine are
precursors of oxalate. This could be the reason why
preterm neonates receiving parenteral nutrition that con-
tains ascorbic acid and glycine excrete higher urinary
oxalate than do neonates receiving a glucose and electro-
lyte solution in the first week of life [60]. Formula-fed
preterm neonates have a higher excretion of oxalate than do
human milk-fed preterm neonates. This can be explained
either by the fact that in formula for preterm neonates there
is a higher concentration of ascorbic acid than in human
milk, or by the mechanism of secondary hyperoxaluria,
described below [61].
Secondary hyperoxaluria If calcium is bound to a com-
pound in the gut, less calcium will be available for oxalate,
and, therefore, oxalate will form complexes with sodium. In
the intestines sodium–oxalate complexes are more readily
absorbed than calcium–oxalate complexes. Thus, enteral
oxalate absorption will increase and higher concentrations
of oxalate will be excreted in the urine. One of these
calcium-binding compounds in the gut is fat. Because fatty
acid absorption is more effective in human milk-fed infants
than in formula-fed infants, relative fat malabsorption can
induce secondary hyperoxaluria in formula-fed neonates
[61]. Moreover, phosphate can also form complexes with
calcium in the gut and lead to secondary hyperoxaluria. In
patients with hypophosphataemic rickets, high intake of
phosphate has been described to lead to hyperoxaluria and
NC, even in a normocalciuric state [62].
Parenteral nutrition seems to increase not only urinary
calcium/citrate ratio (see above), but also urinary oxalate
excretion in preterm neonates. Therefore, parenteral nutri-
tion may be an additional factor in the pathogenesis of
nephrocalcinosis [57, 60].
Miscellaneous
Demographic characteristics NC occurs more often in
Caucasians, male gender, and preterm neonates with a
positive family history of kidney stones [10, 13].
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Nephrotoxic medication, e.g. gentamicin, has also been
found to be a risk factor for NC in preterm infants [13].
Factors inhibiting nephrocalcinosis
Factors inhibiting nephrocalcinosis are shown in Table 1.
Citrate Citrate is an important chelator of calcium stones,
because it forms complexes with calcium that are more
soluble than calcium oxalate and calcium phosphate.
Preterm neonates on mechanical ventilation had a low
urinary citrate excretion when compared with a control
group [63]. Schell et al. confirmed a lower urine citrate/
calcium ratio in preterm neonates with NC as opposed to
those without NC [30]. Likewise, hypocitraturia was a
major risk factor for NC in infants with very low birth
weight, especially in those <1,000 g [64]. In contrast,
White et al. found similar values for urinary citrate in
preterm neonates and healthy term babies. Furthermore,
they found no association between urinary citrate and NC
in preterm neonates [65]. A possible explanation for the
lower excretion of citrate in some preterm neonates might
be tubular reabsorption of citrate to compensate for
episodes of respiratory and metabolic acidosis.
Magnesium Magnesium is another low molecular weight
chelator, which forms complexes with oxalate that are more
soluble than calcium oxalate. The role of urinary magne-
sium excretion in the development of NC has not been
studied in preterm neonates.
Stone-inhibiting macromolecules Urine contains macromo-
lecules, such as osteopontin, nephrocalcin and Tamm-
Horsfall protein, which can inhibit the processes of
nucleation, agglomeration and growth in vitro [66].
Osteopontin, a glycoprotein originally identified as a
component of bone, has been associated with a variety of
functions, including mineralization, signalling and cell
adhesion. The ability of osteopontin to bind and coat
calcium oxalate crystals in renal tubules suggests that
osteopontin may play a role in the prevention of renal
calcium oxalate accumulation [38]. Urinary osteopontin
concentration is significantly lower in premature neonates
than in adults [38]. However, levels do not differ from those
of term infants; therefore, interpretation of these lower
values in the aetiology of NC is still under debate, and
additional studies are warranted. On the other hand,
expression of crystal-binding molecules (hyaluronan and
osteopontin) at the luminal surface of the distal tubular cells
in preterm neonates precedes crystal retention at the distal
nephron epithelium, the first step to NC [67]. Nephrocalcin
and Tamm-Horsfall protein have not been studied in
preterm neonates.
Thiazides Thiazides, diuretics that inhibit sodium reabsorp-
tion in the distal tubules by blocking the thiazide sensitive
Na+Cl− co-transporter, are frequently administered to
preterm neonates with chronic lung disease. Thiazides
decrease urinary excretion of calcium. This hypocalciuric
effect can either be caused by an increase in proximal
reabsorption of sodium and calcium in reaction to distal
natriuretic effect of thiazides, or by a direct stimulatory
effect of thiazides on the distal reabsorption of calcium.
Nevertheless, Toffolo et al. have described preterm neo-
nates with chronic lung disease who were treated with
thiazides and developed NC anyway [43].
Animal model for nephrocalcinosis
In an animal model NC occurred within a few days of
extremely high (40 mg/kg) furosemide administration in
weanling rats. Interestingly, NC in this model was not age
dependent but reflected a property of the loop diuretic itself
[68].
Natural course and long-term effects of nephrocalcinosis
Nephrolithiasis
Rarely, urolithiasis is found in former preterms with severe
NC. Downing et al. describes two patients who needed
nephrolithotomy for ureteral obstruction [69]. That uro-
lithiasis is not a frequent finding in NC is also suggested by
a large prospective study, where none of the patients with
NC developed urolithiasis during a 2-year follow-up period
[70]. Haematuria is not a characteristic of patients with NC,
unless they have urolithiasis [70].
Persistence of nephrocalcinosis
In the majority of patients spontaneous resolution of NC occurs
in the first years of life. However, persistence for several years
has been described [11, 14, 69, 71–74]. In the largest ongoing
study of preterm neonates, NC persisted in 34%, 15% and
10% after 15 months, 30 months and 7.4 (±1.0) years,
respectively (Fig. 2) [70, 75].
Long-term consequences
Long-term consequences are shown in Table 2.
Blood pressure
Although there is evidence that low birth weight is an
important factor in the development of hypertension and the
Pediatr Nephrol (2010) 25:221–230 225
metabolic syndrome in adults, prematurity did, but birth
weight standard deviation score (SDS) did not, predict
hypertension in a large cohort of 19-year-old former
preterms (Table 2) [76, 77]. Likewise, blood pressure of
children born preterm with and without NC did not differ
when they were a mean age of 7.4 years. However, it was
significantly higher than expected for healthy children,
although only a minority of former preterms with (3/42)
and without (2/31) NC in fact had a systolic blood pressure
>95th percentile [75] (Table 2).
Renal growth
Decreased renal growth at the age of 20 years was noted in
former preterms (gestational age <32 weeks) compared to
full-term born controls [5]. Likewise, the kidneys of
patients with and without neonatal NC were significantly
smaller than expected for healthy children of the same
height [75]. It is hypothesized that preterm neonates are
specifically at risk of renal growth impairment because
nephrogenesis peaks at 32 weeks and continues until 36
weeks. So far as limited evidence suggests, NC does not
further impair renal growth.
Glomerular function
Undoubtedly, the most important question is: does NC in very
prematurely born children affect renal function in the long
term? Several (early) studies comprising a limited number of
selected children with preterm NC demonstrated reduced
glomerular filtration rate (GFR) when they were aged
between 1 year and 5 years [69, 71, 72]. In a prospective
follow-up study, after 7.4±1 years, significantly more
children with NC (6/40, 15%) had low GFR (<85 ml/min
per 1.73 m2 body surface area) than did healthy children,
this in contrast to children without neonatal NC (2/32, 6%),
Fig. 3. However, there was no significant difference in GFR
or microalbuminuria between the groups. Furthermore, no
correlation between persistence of NC and low GFR was
found, but the number former preterms with persisting NC
(n=4) was small [75]. This is in contrast with results of a
study by Saarela et al., who found no significant difference
in GFR at a mean age of 4.7 years between 20 former
preterms with and 20 without NC in the neonatal period
[73]. Hoppe et al. and Porter et al. also observed normal
Fig. 3 Estimated GFR of former preterm infants with (n=42) and
without (n=32) neonatal nephrocalcinosis at a mean age of 7.4 years.
+NC with nephrocalcinosis, −NC without nephrocalcinosis. The
asterisk indicates that significantly more children with neonatal
nephrocalcinosis have (mild) chronic renal insufficiency than do
healthy children, P<0.0001. The dashed line shows glomerular
filtration rate <85 ml/min per 1.73 m2 body surface area [75]
Fig. 2 Persistence of nephrocalcinosis (NC) with time, n=70
(continuous line) (95% confidence interval dotted line) [70]
Table 2 Possible long-term effects of nephrocalcinosis and prematu-
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GFR after 3–6 years and 5.8–7.7 years, respectively, in 12
and 14 prematurely born children with NC [14, 74].
In conclusion, long-term follow-up of preterm neonates
with NC demonstrates normal renal function in most
patients. However, an unfavourable effect on renal function
is seen in a small number of children.
Proximal tubular function
How does NC affect long-term tubular function? Jones et
al. studied 11 former preterms when they were aged 4–
5 years with neonatal NC. They found lowmedian TmP/GFR
(tubular maximum of phosphate reabsorption corrected for
glomerular filtration rate) in comparison with reference
values [71]. Likewise, Saarela et al. observed a significantly
higher urine β2-microglobulin/creatinine ratio in 20 chil-
dren with NC than in 20 children without NC as preterm
neonates, when they were a mean age of 4.7 years.
However, in their study, tubular reabsorption of phosphate
(TRP) did not differ significantly in children with and
without NC [73]. In contrast, Downing et al. found
significantly lower TRP (84±2% versus 93±1%, normal
value >85%) in former preterms at the age of 1–2 years
with NC than in former preterms without NC [69]. Kist-van
Holthe et al. also noted a significantly lower TRP in
children with NC (n=39) than in those without NC (n=32)
at a mean age of 7.4±1 years. However, plasma phosphate
was within normal limits in all children [75]. Therefore, the
implication of low TRP in these patients is debatable.
Glucosuria was not found in any of these children [75].
Considering these data, there is no firm evidence for
proximal tubular dysfunction caused by neonatal NC in
former preterms, with the exception of low TRP found in
some patients (Table 2).
Distal tubular function
Downing et al. observed a lower ability to excrete hydrogen
ions in the distal tubule in preterms with NC (n=10) than in
those without NC (n=14) [69]. Median plasma bicarbonate
level was significantly lower in a larger study of children
with (n=42) and without (n=32) neonatal NC. Urine anion
gap of the children with low plasma bicarbonate levels was
inappropriately high, indicating distal rather than proximal
tubular dysfunction [75]. On the other hand, Hoppe et al.
noted no acidosis after a follow-up period of 3–6 years in
12 former preterms with neonatal NC [14].
Most studies found no difference in early morning urine
osmolality between former preterms with and without NC
[14, 69, 74, 75]. On the other hand, two studies
demonstrated early morning urine osmolality to be signif-
icantly lower in former preterms than in healthy children [6,
71]. However, test results indicating impaired concentrating
ability after desmopressin was found in 4/30 children with
neonatal NC at 1 year and in 2/25 at 2 years [70]. In
conclusion, NC in preterm neonates can have long-term
sequelae, mainly for distal tubular acidification. Further-
more, some tubular defects (e.g. reduced early morning
osmolality) cannot solely be attributed to NC but are also
seen in former preterms without neonatal NC.
Hypercalciuria
Hypercalciuria is frequently seen in former preterms with
neonatal NC. Significantly more (9/41, 22%) children with
neonatal NC had hypercalciuria after a mean age of 7.4 years
than expected for healthy children, in contrast to former
preterms without NC (2/32, 6%) [75]. This is in keeping
with the findings of other smaller studies in which hyper-
calciuria with or without NC is described in former
preterms (Table 2) [69, 71, 73, 74, 78].
Prevention and treatment of nephrocalcinosis
in preterm neonates
In children with hypercalciuria, urinary calcium excretion
decreases after administration of thiazides [79]. Neverthe-
less, a study in rats showed that, once established, NC
caused by furosemide is not affected by thiazide therapy, in
spite of its anti-calciuric effect [80]. The effect of thiazides
on the natural course of NC in former preterm neonates has
not yet been studied.
Children with primary hyperoxaluria have been treated
successfully with sodium citrate [81]. Citrate supplementa-
tion in preterm neonates for prevention of NC from day 7
until term at a dose of 0.52 mmol/kg per day did decrease
the urinary calcium/citrate ratio and was safe. Although a
positive trend, no significant decrease in the prevalence of
NC was found [82]. Prevention of NC with higher citrate
dosage in preterm neonates deserves further study.
The balance between high intake of protein, phosphate,
calcium and vitamin D for accretion of tissues on the one
hand, and the risk of renal damage on the other hand,
remains delicate, implying that, also in the newly developed
guidelines for preterm neonates, attention to the develop-
ment of NC is warranted.
Summary
Prevalence of NC of prematurity varied from 7–41% in the
different populations studied. NC in preterm neonates has a
multifactorial aetiology, consisting of low gestational age
and birth weight, often in combination with severe respira-
tory disease, and occurs as result of an imbalance between
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stone-promoting and stone-inhibiting factors. Although
spontaneous resolution of NC occurs in most children, some
are at risk of renal damage later in life, validating the
screening for NC of preterm neonates. Long-term follow-up
of preterm neonates, especially with NC, is warranted.
Further research pertaining to prevention of NC is necessary.
Questions
(Answers appear following the reference list)
1. Nephrocalcinosis (NC) in preterm neonates is pre-





2. The mineral precipitates found in NC in intensive care
treated neonates mainly consists of
a. intratubular calcium oxalate crystals
b. intratubular calcium phosphate crystals
c. interstitial calcium oxalate crystals
d. interstitial calcium phosphate crystals
e. all of the above
3. The aetiology of NC in preterm neonates is multifac-
torial. The following factor is important
a. low gestational age
b. high calcium and phosphate intake
c. severe respiratory disease
d. hypercalciuria
e. all of the above
4. Phosphate intake can influence the risk of developing
NC in the case of
a. high phosphate intake
b. low phosphate intake
c. normal phosphate intake
d. low as well as high phosphate intake
5. As a long term consequence(s) of NC in preterm
neonates can be seen
a. haematuria
b. hypertension
c. decreased glomerular filtration rate
d. decreased renal growth
6. The most probable long-term outcome of NC in
preterm neonates is
a. spontaneous resolution of NC
b. decreased glomerular function
c. distal tubular dysfunction
d. persistence of NC
7. High blood pressure in follow-up studies of neonates
with NC is related to
a. severity of NC
b. persistence of NC
c. kidney growth
d. prematurity per se
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2. a. intratubular calcium oxalate crystals
3. e. all of the above
4. d. low as well as high phosphate intake
5. c. decreased glomerular filtration rate
6. a. spontaneous resolution of NC
7. d. prematurity per se
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